Increased c-MET and TGF-β pathway activity may promote tumor progression in glioblastoma via invasion, migration, angiogenesis, cell survival, SC maintenance, and immune evasion13,23–28, however, their potential interactions may not have been sufficiently studied. This evidence concerns the gene TGFB1 and neoplasm.